---
title: "FAT3"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene FAT3"
tags: ['GeneFAT3', 'FrameshiftMutations', 'Cancer', 'Chemotherapy', 'TargetedTherapies', 'CellMovement', 'TissueOrganization', 'ClinicalTrials']
---

# Gene FAT3

## Information about Gene

**Function:** The FAT3 gene provides instructions to make a protein that plays a role in cell movement and organization of tissues during embryonic development.

**External IDs & Genomic Location:**
- HGNC: 24612
- NCBI Entrez: 79633
- Ensembl: ENSG00000124356
- OMIM: 611267
- UniProtKB/Swiss-Prot: Q6ZN16
- Genomic Location: Chromosome 11q14.3

**Aliases:** CDHF11, ME5, hFAT-3

## Mutation Information

**AA mutation list:**
- p.Leu2455Serfs*30
- p.Ser2921Leufs*4
- p.Asp3546Glyfs*54
- p.Val4326Alafs*20
- p.Leu2447Profs*31

**Mutation Type:** Frameshift mutations

**dbSNP ID:**
- rs786202382
- rs3918228
- rs140195263
- rs775564055
- rs794727984

**Somatic SNVs/InDels with dbSNP ID:**
- rs1057518777
- rs1599657

## Related Disease

FAT3 mutations have been reported in tumors like glioblastoma, mammary gland adenocarcinoma, ovarian serous carcinoma, and endometrial cancer.

## Treatment and Prognosis

There is no known cure for FAT3 mutations-related diseases. Treatment is based on chemotherapy, surgery, or radiation therapy depending on the type and stage of the cancer.

## Drug Response

There is no specific drug for FAT3 mutations. However, there are many ongoing clinical trials for cancer treatments, and targeted therapies that are under testing.

##References:

- TCGA Research Network (2015): Comprehensive genomic characterization of head and neck squamous cell carcinomas. Cell 161(3): 755-762. doi: 10.1016/j.cell.2015.05.02
- Engel, Ulla (2018): The Enigma of Giant Cadherins. In PCM-Biol. doi: 10.1007/978-3-319-92666-7_16
- UniProt Consortium (2019): UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. doi: 10.1093/nar/gky1049

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**